Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy.
Liang K, Smith ER, Aoi Y, Stoltz KL, Katagi H, Woodfin AR, Rendleman EJ, Marshall SA, Murray DC, Wang L, Ozark PA, Mishra RK, Hashizume R, Schiltz GE, Shilatifard A.
Liang K, et al. Among authors: stoltz kl.
Cell. 2018 Oct 18;175(3):766-779.e17. doi: 10.1016/j.cell.2018.09.027.
Cell. 2018.
PMID: 30340042
Free PMC article.